Gilead Sciences Stock Alpha and Beta Analysis
| GILD Stock | USD 92.41 1.06 1.16% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Gilead Sciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Gilead Sciences over a specified time horizon. Remember, high Gilead Sciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Gilead Sciences' market risk premium analysis include:
Beta 0.47 | Alpha 0.22 | Risk 1.42 | Sharpe Ratio 0.19 | Expected Return 0.27 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Gilead |
Gilead Sciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Gilead Sciences market risk premium is the additional return an investor will receive from holding Gilead Sciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Gilead Sciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Gilead Sciences' performance over market.| α | 0.22 | β | 0.47 |
Gilead Sciences expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Gilead Sciences' Buy-and-hold return. Our buy-and-hold chart shows how Gilead Sciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Gilead Sciences Market Price Analysis
Market price analysis indicators help investors to evaluate how Gilead Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Gilead Sciences shares will generate the highest return on investment. By understating and applying Gilead Sciences stock market price indicators, traders can identify Gilead Sciences position entry and exit signals to maximize returns.
Gilead Sciences Return and Market Media
The median price of Gilead Sciences for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 is 85.21 with a coefficient of variation of 5.77. The daily time series for the period is distributed with a sample standard deviation of 4.94, arithmetic mean of 85.73, and mean deviation of 3.93. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
| Gilead Sciences dividend paid on 27th of September 2024 | 09/27/2024 |
1 | Scientific Leadership Spotlighted as Gilead Presents Research Data Across Its Broad and Innovative HIV Treatment Portfolio and Pipeline | 11/12/2024 |
2 | Gilead Prices 3.5 Billion of Senior Unsecured Notes | 11/14/2024 |
3 | FDA Accepts SNY and REGNs Dupixent Re-Submitted sBLA for Urticaria | 11/18/2024 |
4 | TOUCH, la Alianza de Personas de la Raza Negra contra el Cncer de Seno y sus aliados presentan el centro de recursos el Oasis de TNBC para Personas de la Raza N... | 11/19/2024 |
5 | FirstLight and Maine Connectivity Authority Sign Agreement to Build 450 Miles of Fiber in Western Maine | 11/20/2024 |
6 | Cypress Capital Group Reduces Holdings in Gilead Sciences, Inc. | 11/21/2024 |
7 | Gilead Announces Layoffs Amid Strong Q3 Performance, HIV Drug Sales Surge | 11/22/2024 |
8 | Antibody Drug Conjugate Market Industry Trends and Forecasts to 2035, Featuring Profiles of Key Players ADC Therapeutics, Byondis, Daiichi Sankyo, Genentech, Gi... | 11/26/2024 |
About Gilead Sciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Gilead or other stocks. Alpha measures the amount that position in Gilead Sciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0395 | 0.0344 | 0.0377 | 0.0268 | Price To Sales Ratio | 3.34 | 3.95 | 3.73 | 3.54 |
Gilead Sciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Gilead Sciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Gilead Sciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Gilead Sciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Gilead Sciences. Please utilize our Beneish M Score to check the likelihood of Gilead Sciences' management manipulating its earnings.
| 6th of February 2024 Upcoming Quarterly Report | View | |
| 25th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Gilead Sciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Gilead Sciences Backtesting, Gilead Sciences Valuation, Gilead Sciences Correlation, Gilead Sciences Hype Analysis, Gilead Sciences Volatility, Gilead Sciences History and analyze Gilead Sciences Performance. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Gilead Sciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.